Significantly, SNX4 has already been linked with the etiology of AD, with SNX4 protein levels being decreased by 70% in the brains of severe Alzheimer’s disease (AD) cases [212]. Here, SNX4 is linked to early-onset autosomal dominant Alzheimer disease.